AI drug discovery unicorn Insilico Medicine is set to sign a deal with Saudi Arabia’s Aramco and a subsidiary during Hong Kong leader John Lee Ka-chiu’s official visit to the country.
Hong Kong AI firm Insilico, Aramco to partner on development of sustainable fuels and materials
Share this: